We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

How about door No. 3?

23 March 2016 By Robert Cyran

Affymetrix is in a bind. Rival Thermo Fisher made a solid $1.3 bln offer that’s now below the target’s share price. Former bosses swooped in with a higher non-binding bid backed by little-known Chinese funders. The board must choose – and fast. The question: Does it feel lucky?

This content is for Subscribers only

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)